Access Bio, Inc. (KOSDAQ:950130)
South Korea
· Delayed Price · Currency is KRW 4,675.00
+75.00 (1.63%)
Apr 1, 2025, 3:30 PM KST
Access Bio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Other Revenue | - | - | - | 0 | - | Upgrade
|
| Revenue | 112,463 | 348,643 | 1,033,863 | 505,112 | 121,797 | Upgrade
|
| Revenue Growth (YoY) | -67.74% | -66.28% | 104.68% | 314.71% | 182.86% | Upgrade
|
| Cost of Revenue | 59,197 | 178,765 | 214,488 | 109,147 | 31,164 | Upgrade
|
| Gross Profit | 53,266 | 169,878 | 819,375 | 395,965 | 90,634 | Upgrade
|
| Selling, General & Admin | 44,819 | 197,435 | 343,560 | 55,945 | 14,485 | Upgrade
|
| Research & Development | 10,837 | 16,081 | 7,316 | 4,894 | 4,006 | Upgrade
|
| Other Operating Expenses | 103.17 | 133.52 | 93.09 | 82.15 | 76.18 | Upgrade
|
| Operating Expenses | 65,867 | 147,956 | 351,137 | 136,296 | 24,097 | Upgrade
|
| Operating Income | -12,602 | 21,922 | 468,238 | 259,669 | 66,536 | Upgrade
|
| Interest Expense | -3,470 | -3,711 | -6,233 | -3,350 | -1,867 | Upgrade
|
| Interest & Investment Income | 14,593 | 14,433 | 5,710 | 211.98 | 126.88 | Upgrade
|
| Currency Exchange Gain (Loss) | -1,403 | -198.98 | -169.12 | -546.48 | 721.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 8,837 | -41,370 | -7,750 | 757.1 | -61.01 | Upgrade
|
| EBT Excluding Unusual Items | 5,954 | -8,926 | 459,796 | 256,742 | 65,456 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4,707 | 1,080 | 12.79 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.16 | -0.89 | -41.39 | 18.46 | -98.89 | Upgrade
|
| Asset Writedown | -1,389 | 1,967 | -1.1 | - | -2,896 | Upgrade
|
| Other Unusual Items | - | - | 3,929 | - | 17.43 | Upgrade
|
| Pretax Income | -143.86 | -5,879 | 463,696 | 256,760 | 62,479 | Upgrade
|
| Income Tax Expense | 936 | -580.48 | 113,951 | 66,683 | 14,667 | Upgrade
|
| Earnings From Continuing Operations | -1,080 | -5,299 | 349,746 | 190,077 | 47,812 | Upgrade
|
| Minority Interest in Earnings | 732.29 | 2,126 | -3,075 | -387.22 | 460.3 | Upgrade
|
| Net Income | -347.58 | -3,173 | 346,670 | 189,690 | 48,272 | Upgrade
|
| Net Income to Common | -347.58 | -3,173 | 346,670 | 189,690 | 48,272 | Upgrade
|
| Net Income Growth | - | - | 82.76% | 292.96% | - | Upgrade
|
| Shares Outstanding (Basic) | 34 | 34 | 34 | 36 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 34 | 38 | 37 | 35 | Upgrade
|
| Shares Change (YoY) | 1.38% | -10.73% | 1.46% | 7.75% | 21.66% | Upgrade
|
| EPS (Basic) | -10.15 | -93.91 | 10050.42 | 5328.07 | 1432.85 | Upgrade
|
| EPS (Diluted) | -10.15 | -93.91 | 9212.00 | 5127.00 | 1392.00 | Upgrade
|
| EPS Growth | - | - | 79.68% | 268.32% | - | Upgrade
|
| Free Cash Flow | 17,853 | -122,498 | 350,444 | 129,398 | 25,256 | Upgrade
|
| Free Cash Flow Per Share | 521.24 | -3625.74 | 9259.21 | 3468.64 | 729.46 | Upgrade
|
| Gross Margin | 47.36% | 48.73% | 79.25% | 78.39% | 74.41% | Upgrade
|
| Operating Margin | -11.21% | 6.29% | 45.29% | 51.41% | 54.63% | Upgrade
|
| Profit Margin | -0.31% | -0.91% | 33.53% | 37.55% | 39.63% | Upgrade
|
| Free Cash Flow Margin | 15.88% | -35.14% | 33.90% | 25.62% | 20.74% | Upgrade
|
| EBITDA | 7,476 | 37,882 | 479,065 | 265,733 | 69,950 | Upgrade
|
| EBITDA Margin | 6.65% | 10.87% | 46.34% | 52.61% | 57.43% | Upgrade
|
| D&A For EBITDA | 20,078 | 15,960 | 10,826 | 6,064 | 3,414 | Upgrade
|
| EBIT | -12,602 | 21,922 | 468,238 | 259,669 | 66,536 | Upgrade
|
| EBIT Margin | -11.21% | 6.29% | 45.29% | 51.41% | 54.63% | Upgrade
|
| Effective Tax Rate | - | - | 24.57% | 25.97% | 23.47% | Upgrade
|
| Advertising Expenses | 722.23 | 678.33 | 1,523 | 1,113 | 1,025 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.